David Burns

(Former)

View graph of relations

Most downloaded publications

Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns, Emma Martin, Andrew Bell, Paul Moss, Charles Craddock, Christopher Fox & Sridhar Chaganti, Jun 2016, In : Bone Marrow Transplantation. 51, 6, p. 825-832

Research output: Contribution to journal › Article

122 downloads
Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease
David Burns, Gordon Ryan, Eszter Nagy, Paul Murray & Heather Long, 29 Oct 2019, In : Frontiers in immunology. 10, 2489.

Research output: Contribution to journal › Article

34 downloads

Recent publications

Non-uniform in vivo Expansion of Epstein-Barr Virus-Specific T-Cells Following Donor Lymphocyte Infusion for Post-transplant Lymphoproliferative Disease
David Burns, Gordon Ryan, Eszter Nagy, Paul Murray & Heather Long, 29 Oct 2019, In : Frontiers in immunology. 10, 2489.

Research output: Contribution to journal › Article

Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns, Emma Martin, Andrew Bell, Paul Moss, Charles Craddock, Christopher Fox & Sridhar Chaganti, Jun 2016, In : Bone Marrow Transplantation. 51, 6, p. 825-832

Research output: Contribution to journal › Article

Memory B cell reconstitution following allogeneic haematopoietic stem cell transplantation is an EBV-associated transformation event
David Burns, Rosemary Tierney, Claire Shannon-Lowe, Charlotte Inman, Christopher Fox, Sridhar Chaganti, Charles Craddock, Paul Moss, Alan Rickinson, Martin Rowe & Andrew Bell, 17 Dec 2015, In : Blood. 126, 25, p. 2665-2675 11 p.

Research output: Contribution to journal › Article

View all (7)